...
首页> 外文期刊>Angewandte Chemie >Noninvasive Staging of Kidney Dysfunction Enabled by Renal-Clearable Luminescent Gold Nanoparticles
【24h】

Noninvasive Staging of Kidney Dysfunction Enabled by Renal-Clearable Luminescent Gold Nanoparticles

机译:肾脏可清除的发光金纳米粒子对肾脏功能障碍的无创分期。

获取原文
获取原文并翻译 | 示例
           

摘要

As a "silent killer", kidney disease is often hardly detected at an early stage but can cause lethal kidney failure later on. Thus, a preclinical imaging technique that can readily differentiate between the stages of kidney dysfunction is highly desired for improving our fundamental understanding of kidney disease progression. Herein, we report that in vivo fluorescence imaging, enabled by renal-clearable near-infra-red-emitting gold nanoparticles, can noninvasively detect kidney dysfunction, report on the dysfunctional stages, and even reveal adaptive function in a mouse model of unilateral obstructive nephropathy, which cannot be diagnosed with routine kidney function markers. These results demonstrate that low-cost fluorescence kidney functional imaging is highly sensitive and useful for the longitudinal, noninvasive monitoring of kidney dysfunction progression in preclinical research.
机译:作为“沉默的杀手”,肾脏疾病通常很难在早期发现,但后来可能导致致命的肾衰竭。因此,迫切需要一种可以在肾脏功能障碍的各个阶段之间进行区分的临床前成像技术,以改善我们对肾脏疾病进展的基本认识。在本文中,我们报道了通过肾脏可清除的近红外发射金纳米颗粒实现的体内荧光成像可以无创地检测肾脏功能障碍,报告功能障碍的阶段,甚至揭示单侧阻塞性肾病小鼠模型的适应性功能,无法通过常规肾功能标志物进行诊断。这些结果表明,低成本的荧光肾功能成像对临床前研究中的肾功能不全进展的纵向,非侵入性监测具有高度敏感性,并且非常有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号